The Evolving Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer: Opportunities for Pharmacists to Optimize Treatment Selection
This article will examine the pathway to anaplastic lymphoma kinase (ALK) therapy resistance mutations in selection of an appropriate ALK inhibitor
Managed Care Perspectives on Targeted Therapies for Hepatocellular Carcinoma (HCC)
This webinar will educate managed care professionals and pharmacists on the patient populations at highest risk, current and emerging treatment options for HCC, as well as its impact on patient outcomes and costs in a managed care setting.
Directions in Oncology Pharmacy ® 2019
Directions in Oncology Pharmacy 2019 will provide education to pharmacists practicing in the oncology clinic, hospital, and specialty pharmacy settings.
Integration of PARP Inhibitors for the Treatment of Ovarian Cancer: Significance for Payers and Specialty Pharmacies
This program will analyze approved PARP inhibitor therapies for ovarian cancer through applied knowledge of clinical trial data, mechanisms of action, and adverse effect profiles.